Jack Oswald is co-founder, CEO, CTO and one of the inventors of ISOThrive. ISOThrive is a novel microbiome inspired therapeutic for gastroessophageal reflux disease (GERD). With a $16B annual market in the US alone, this is a company to watch. Jack is a Member of the Board of Trustees, as well as on the faculty of the School of Engineering at the University of California, Merced. Jack is a graduate of Dartmouth College (AB Engineering) and Harvard Business School (MBA). He is an engaging speaker and has spoken at microbiome conferences across the country and TedX events.